Exercise and Cognitive Rehabilitation for Cancer Survivors
(E-Co Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new mobile app called E-Co, which combines exercise and brain training to assist cancer survivors experiencing memory or thinking issues after treatment. The main goal is to determine the feasibility of this approach and its effectiveness in improving cognitive abilities. It targets survivors aged 60 and above who have completed curative cancer treatments, including those still on hormone therapies. Participants must be able to walk a short distance and speak English. As an unphased trial, this study provides a unique opportunity for participants to contribute to innovative research that could enhance cognitive health for cancer survivors.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, patients on endocrine therapies are allowed to enroll, suggesting that some medications may be continued.
What prior data suggests that this intervention is safe for cancer survivors?
Research suggests that exercise might improve brain function after cancer treatment. Some studies have explored exercise's effects on cancer survivors and found it may lower cancer risk and enhance certain brain functions.
However, the safety of exercise programs for cancer survivors remains unclear. The Exercise Harms Reporting Method (ExHaRM) aims to better understand any risks. Currently, solid information on negative effects from these exercises is limited.
Overall, exercise appears promising for addressing thinking and memory issues after cancer treatment. More research is needed to confirm the safety of these programs.12345Why are researchers excited about this trial?
Researchers are excited about the E-Co treatment because it uniquely combines physical exercise with cognitive rehabilitation in a single intervention for cancer survivors. Unlike typical treatments that might focus solely on physical recovery or mental health separately, E-Co integrates a mobile health exercise program with a cognitive rehabilitation strategy. This innovative approach targets both body and mind, aiming to enhance overall quality of life and cognitive function simultaneously. By addressing these areas together, E-Co has the potential to offer more comprehensive support than traditional options.
What evidence suggests that the E-Co intervention is effective for improving cognition in cancer survivors?
Research shows that exercise can improve brain function in cancer survivors. Studies have found that aerobic exercise, such as walking or cycling, boosts thinking and memory after cancer treatment. Specifically, high-intensity interval training, involving short bursts of intense exercise, has been linked to positive changes in brain structure and function. This trial will evaluate the E-Co intervention, which combines exercise with cognitive rehabilitation, including mental exercises to enhance brainpower. Early evidence suggests that this combined approach may help cancer survivors regain cognitive abilities more effectively.12367
Who Is on the Research Team?
Kah Poh Loh, MD
Principal Investigator
University of Rochester
Are You a Good Fit for This Trial?
This trial is for cancer survivors aged 60 or older who can walk, have finished their main cancer treatments, and may still be on hormone therapy. They should not have any health issues that make exercise risky, as decided by their oncologist. Participants must speak English and score ≤10 on a cognitive impact scale.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants undergo a combined mobile health exercise and cognitive rehabilitation intervention
Follow-up
Participants are monitored for cognitive outcomes and intervention feasibility
What Are the Treatments Tested in This Trial?
Interventions
- E-Co
E-Co is already approved in United States for the following indications:
- Cognitive rehabilitation in older cancer survivors
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor